Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA–IIIB) lung cancer

Abstract
The 5-year survival rate of patients with tumors sized ≤3 cm after neoadjuvant therapy (n = 41) rates was 55.1% with an MST of 71 months, while it was 29.1% for

This publication has 0 references indexed in Scilit: